Efficacy and safety of immunotherapy with interferon-gamma in the management of chronic sulfur mustard-induced cutaneous complications: Comparison with topical betamethasone 1%

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Panahi, Yunes ^a   Sahebkar, Amirhossein ^b   Davoudi, Seyyed Masoud ^a   Amiri, Mojtaba ^a   Beiraghdar, Fatemeh ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BETAMETHASONE VALERATE; CREATININE; GAMMA INTERFERON; MUSTARD GAS; POTASSIUM; SODIUM; BETAMETHASONE; CHEMICAL WARFARE AGENT;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; ATOPIC DERMATITIS; BEDTIME DOSAGE; BLOOD CELL COUNT; BLURRED VISION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SELF ADMINISTRATION; HUMAN; IMMUNOTHERAPY; INJECTION SITE ATROPHY; INJECTION SITE NODULE; INJECTION SITE PAIN; INJECTION SITE SWELLING; INJECTION SITE URTICARIA; INJECTION SITE WARMTH; MYALGIA; POTASSIUM BLOOD LEVEL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SKIN REDNESS; SODIUM BLOOD LEVEL; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; VERTIGO; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; PATHOPHYSIOLOGY; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; BETAMETHASONE; CHEMICAL WARFARE AGENTS; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; MUSTARD GAS; QUALITY OF LIFE; SKIN; SKIN DISEASES;

EID: 84859707548     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/285274     Document Type: Article

References (35)

1. Wormser U., Toxicology of mustard gas Trends in Pharmacological Sciences 1991 12 4 164 167
2. Ghabili K., Agutter P. S., Ghanei M., Ansarin K., Panahi Y., Shoja M. M., Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics Critical Reviews in Toxicology 2011 41 5 384 403
3. Shakarjian M. P., Heck D. E., Gray J. P., Sinko P. J., Gordon M. K., Casillas R. P., Heindel N. D., Gerecke D. R., Laskin D. L., Laskin J. D., Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure Toxicological Sciences 2010 114 1 5 19
4. Evison D., Hinsley D., Rice P., Regular review: chemical weapons British Medical Journal 2002 324 7333 332 335 (Pubitemid 34142753)
5. Bullman T., Kang H., A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gas Annals of Epidemiology 2000 10 5 333 338 (Pubitemid 30609616)
6. Balali-Mood M., Hefazi M., The clinical toxicology of sulfur mustard Archives of Iranian Medicine 2005 8 3 162 179 (Pubitemid 40903462)
7. Kehe K., Szinicz L., Medical aspects of sulphur mustard poisoning Toxicology 2005 214 3 198 209 (Pubitemid 41406260)
8. Khateri S., Ghanei M., Keshavarz S., Soroush M., Haines D., Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent Journal of Occupational and Environmental Medicine 2003 45 11 1136 1143 (Pubitemid 37420858)
9. Moin A., Ghazanfari T., Davoudi S. M., Emadi N., Panahi Y., Hassan Z. M., Soroush M. R., Khateri S., Amini R., Naghizadeh M. M., Yaraee R., Ghasemi H., Shams J., Mahdavi M. R. V., Moaiedmohseni S., Nadoushan M. R. J., Merasizadeh J., Faghihzadeh S., Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran Toxin Reviews 2009 28 1 24 29
10. Ghanei M., Poursaleh Z., Harandi A. A., Emadi S. E., Emadi S. N., Acute and chronic effects of sulfur mustard on the skin: a comprehensive review Cutaneous and Ocular Toxicology 2010 29 4 269 277
11. United Nations Security Council, Reports of the specialists appointed by the Secretary General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. Security Council of the United Nations document S/16433, New York, NY, USA, 1986
12. Hefazi M., Maleki M., Mahmoudi M., Tabatabaee A., Balali-Mood M., Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 1620 years after exposure International Journal of Dermatology 2006 45 9 1025 1031 (Pubitemid 44317113)
13. Momeni A. Z., Enshaeih S., Meghdadi M., Amindjavaheri M., Skin manifestations of mustard gas: a clinical study of 535 patients exposed to mustard gas Archives of Dermatology 1992 128 6 775 780
14. Shohrati M., Davoudi M., Ghanei M., Peyman M., Peyman A., Cutaneous and ocular late complications of sulfur mustard in Iranian veterans Cutaneous and Ocular Toxicology 2007 26 2 73 81 (Pubitemid 47027134)
15. Boguniewicz M., Advances in the understanding and treatment of atopic dermatitis Current Opinion in Pediatrics 1997 9 6 577 581 (Pubitemid 28021431)
16. Kang K., Stevens S. R., Pathophysiology of atopic dermatitis Clinics in Dermatology 2003 21 2 116 121 (Pubitemid 36428982)
17. Miller C. H. T., Maher S. G., Young H. A., Clinical use of interferon-γ Annals of the New York Academy of Sciences 2009 1182 69 79
18. Reinhold U., Kukel S., Brzoska J., Kreysel H. W., Systemic interferon gamma treatment in severe atopic dermatitis Journal of the American Academy of Dermatology 1993 29 1 58 63 (Pubitemid 23197197)
19. Hanifin J. M., Schneider L. C., Leung D. Y. M., Ellis C. N., Jaffe H. S., Izu A. E., Bucalo L. R., Hirabayashi S. E., Tofte S. J., Cantu-Gonzales G., Milgrom H., Boguniewicz M., Cooper K. D., Recombinant interferon gamma therapy for atopic dermatitis Journal of the American Academy of Dermatology 1993 28 2 189 197 (Pubitemid 23053704)
20. Stevens S. R., Hanifin J. M., Hamilton T., Tofte S. J., Cooper K. D., Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels Archives of Dermatology 1998 134 7 799 804 (Pubitemid 28350182)
21. Panahi Y., Davoudi S. M., Sadr S. B., Naghizadeh M. M., Mohammadi-Mofrad M., Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans International Journal of Dermatology 2008 47 6 557 561 (Pubitemid 351676493)
22. Panahi Y., Sahebkar A., Amiri M., Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition. In press
23. Panahi Y., Davoudi S. M., Sahebkar A., Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial. Cutaneous and Ocular Toxicology. In press
24. Stalder J. F., Taieb A., Atherton D. J., Bieber T., Bonifazi E., Broberg A., Calza A., Coleman R., De Prost Y., Diepgen T. L., Gelmetti C., Giannetti A., Harper J., Kunz B., Lachapelle J. M., Langeland T., Lever R., Oranje A. P., Queille-Roussel C., Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis Dermatology 1993 186 1 23 31 (Pubitemid 23032316)
25. Aghaei S., Sodaifi M., Jafari P., Mazharinia N., Finlay A. Y., DLQ1 scores in vitiligo: reliability and validity of the Persian version BMC Dermatology 2004 4, article 8
26. Hengge U. R., Ruzicka T., Schwartz R. A., Cork M. J., Adverse effects of topical glucocorticosteroids Journal of the American Academy of Dermatology 2006 54 1 1 15
27. Grossman R. M., Chevret S., Abi-Rached J., Blanchet F., Dubertret L., Long-term safety of cyclosporine in the treatment of psoriasis Archives of Dermatology 1996 132 6 623 629 (Pubitemid 26174103)
28. Krumbhaar E. B., Krumbhaar H. D., The blood and bone marrow in yellow cross gas (Mustard gas) poisoning Journal of Medical Research 1919 40 497 506
29. Billiau A., Heremans H., Vermeire K., Matthys P., Immunomodulatory properties of interferon-γ : an update Annals of the New York Academy of Sciences 1998 856 22 32
30. Nuttall T. J., Knight P. A., McAleese S. M., Lamb J. R., Hill P. B., T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis Veterinary Immunology and Immunopathology 2002 87 3-4 379 384 (Pubitemid 34665264)
31. Iwasaki T., Hasegawa A., A randomized comparative clinical trial of recombinant canine interferon- (KT-100) in atopic dogs using antihistamine as control Veterinary Dermatology 2006 17 3 195 200
32. Gentilhomme E., Reano A., Pradel D., Bergier J., Schmitt D., Neveux Y., In vitro dermal intoxication by bis(chloroethyl)sulfide. Effect on secondary epidermization Cell Biology and Toxicology 1998 14 1 1 11 (Pubitemid 28092394)
33. Werrlein R. J., Madren-Whalley J. S., Effects of sulfur mustard on the basal cell adhesion complex Journal of Applied Toxicology 2000 20 1 S115 S123
34. Kan R. K., Pleva C. M., Hamilton T. A., Anderson D. R., Petrali J. P., Sulfur mustard-induced apoptosis in hairless guinea pig skin Toxicologic Pathology 2003 31 2 185 190 (Pubitemid 36374007)
35. Davoudi S. M., Keshavarz S., Sadr B., Shohrati M., Naghizadeh M. M., Farsinejad K., Rashighi-Firouzabadi M., Zartab H., Firooz A., Skin hydration and transepidermal water loss in patients with a history of sulfur mustard contact: a case-control study Journal of the European Academy of Dermatology and Venereology 2009 23 8 940 944